跳至主要内容
临床试验/NL-OMON32013
NL-OMON32013撤回不适用

COPD: Transition of systemic inflammation into multiorgan pathology (study 3). - Multiorgan pathology in COPD

niversitair Medisch Centrum Groningen0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age 40-75 years
  • Age, pack years, FEV1/FVC and FEV1% predicted must fit in one of 2 groups of table 4.3
  • Physically and mentally able to undergo the total study protocol
  • Written informed consent

排除标准

  • Participation in another study
  • Alpha-1-antitrypsin deficiency
  • Selected within the red made gradation of the 1-3 co-morbidity list in the ACE-27
  • Active pulmonary infection like tuberculosis, pneumonia, flue, tracheobronchitis
  • Active extra-pulmonary infection like hepatitis A-C, cystitis, gastro-enteritis etc
  • Pulmonary diseases like sarcoidosis, IPF, silicosis, hypersensitivity pneumonitis
  • Life threatening diseases like carcinoma, AIDS (including HIV+), acute leukaemia etc
  • Medication that may affect the results of the study: NSAID*s, immunosuppressive agents like prednisolon, metotrexate, azathioprine, sintrom tablets

研究者

相似试验